Trending News

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

Supreme Court Eliminates Heightened Discrimination Standard Under Title VII

Cleaning the Cupboard—Six More Decisions in One Day, and a Largely Harmonious Court - SCOTUS Today

U.S. Supreme Court Holds Majority-Group Plaintiffs Are Not Subject to a Heightened Evidentiary Standard Under Title VII

Supreme Court Clarifies Title VII Evidentiary Standards in “Reverse Discrimination” Cases, Removing Heightened Standard

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Monthly information on share capital and company voting rights
Posted On Friday, July 04, 2025
Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessa’s Initiation of Clinical Development of ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist
Posted On Friday, July 04, 2025
Theratechnologies to Announce Second Quarter 2025 Financial Results
Posted On Thursday, July 03, 2025
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Posted On Thursday, July 03, 2025
Opus Genetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Thursday, July 03, 2025
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Thursday, July 03, 2025
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Thursday, July 03, 2025
Monte Rosa Announces Publication in Science of Key Insights that Enable Next Generation Molecular Glue Degrader Medicines
Posted On Thursday, July 03, 2025
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Posted On Thursday, July 03, 2025
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Posted On Thursday, July 03, 2025
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Thursday, July 03, 2025
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Thursday, July 03, 2025
Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team
Posted On Thursday, July 03, 2025
Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak
Posted On Wednesday, July 02, 2025
Raw Garden Announces California Cannabis Deals for July 4th to 7/10
Posted On Wednesday, July 02, 2025
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Wednesday, July 02, 2025
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Wednesday, July 02, 2025
Oragenics Completes Approximately $16.5 Million Offering
Posted On Wednesday, July 02, 2025
Lixte Biotechnology Holdings, Inc. Announces the Closing of $5.0 Million Private Placement Priced at the Market
Posted On Wednesday, July 02, 2025
4DMT Announces Accelerated 4D-150 Phase 3 Development in Wet AMD and Streamlined Organization to Drive Late-Stage Execution
Posted On Wednesday, July 02, 2025
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Posted On Wednesday, July 02, 2025
I-Mab Presents Positive Givastomig Phase 1b Dose Escalation Data in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers at ESMO GI 2025
Posted On Wednesday, July 02, 2025
Lynozyfic™ (linvoseltamab-gcpt) Receives FDA Accelerated Approval for Treatment of Relapsed or Refractory Multiple Myeloma
Posted On Wednesday, July 02, 2025
Cyclacel Pharmaceuticals Announces Stock Split
Posted On Wednesday, July 02, 2025
Windtree Announces Issuance of Istaroxime Patent for the United States for Acute Heart Failure
Posted On Wednesday, July 02, 2025

1
2
3
4
5
6
7
8
9
…
Next page
Last page

Print